Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Feb;117(4):647–652. doi: 10.1111/j.1476-5381.1996.tb15239.x

Lack of anticonvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats.

A Zanotti 1, R Mariot 1, A Contarino 1, M Lipartiti 1, P Giusti 1
PMCID: PMC1909353  PMID: 8646409

Abstract

1. Development of anticonvulsant tolerance and benzodiazepine (BZD) receptor down-regulation has been reported to occur upon chronic administration of conventional BZDs. We compared the effect of chronic treatment with imidazenil, a new BZD partial agonist, and diazepam in rats. 2. After acute administration, imidazenil was more potent though less effective than diazepam in protecting from bicuculline-induced seizure. The time-course analysis of two peak equieffective doses of imidazenil (2.5 mumol kg-1 p.o.) and diazepam (35 mumol kg-1, p.o.) showed a longer lasting action of the former drug. 3. The anticonvulsant efficacy of diazepam (35 mumol kg-1, p.o.) was reduced in rats given chronic diazepam (35 mumol kg-1 p.o., 3 times a day for 8-15 days). No tolerance to imidazenil (2.5 mumol kg-1, p.o.) was apparent after 130-day administration with imidazenil (2.5 mumol kg-1, p.o., 3 times a day). 4. Plasma levels of imidazenil and diazepam, assessed 30 min after administration, were not changed in chronically treated animals. 5. In rats made tolerant to diazepam, the maximum number of [3H]-flumazenil binding sites were reduced in both cerebral cortex (-36%) and cerebellum (-42%). No changes in [3H]-flumazenil binding were found in chronic imidazenil-treated rats. 6. Specific [3H]-flumazenil binding in vivo was decreased in the forebrain of chronic diazepam- but not of chronic imidazenil-treated animals. 7. These data indicate that imidazenil possesses a very low tolerance potential to its anticonvulsant activity and does not affect BZD receptor density even after prolonged administration.

Full text

PDF
647

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auta J., Giusti P., Guidotti A., Costa E. Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat. J Pharmacol Exp Ther. 1994 Sep;270(3):1262–1269. [PubMed] [Google Scholar]
  2. Boast C. A., Gerhardt S. C. Lack of tolerance or withdrawal effects in mice after chronic administration of the non-sedating anxiolytic, CGS 9896. Pharmacol Biochem Behav. 1987 Mar;26(3):601–606. doi: 10.1016/0091-3057(87)90172-9. [DOI] [PubMed] [Google Scholar]
  3. Feely M., Boyland P., Picardo A., Cox A., Gent J. P. Lack of anticonvulsant tolerance with RU 32698 and Ro 17-1812. Eur J Pharmacol. 1989 May 19;164(2):377–380. doi: 10.1016/0014-2999(89)90482-2. [DOI] [PubMed] [Google Scholar]
  4. Garratt J. C., Gent J. P., Feely M., Haigh J. R. Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential? Eur J Pharmacol. 1988 Jan 5;145(1):75–80. doi: 10.1016/0014-2999(88)90351-2. [DOI] [PubMed] [Google Scholar]
  5. Gent J. P., Feely M. P., Haigh J. R. Differences between the tolerance characteristics of two anticonvulsant benzodiazepines. Life Sci. 1985 Sep 2;37(9):849–856. doi: 10.1016/0024-3205(85)90520-x. [DOI] [PubMed] [Google Scholar]
  6. Ghiani C. A., Serra M., Motzo C., Giusti P., Cuccheddu T., Porceddu M. L., Biggio G. Chronic administration of an anticonvulsant dose of imidazenil fails to induce tolerance of GABAA receptor function in mice. Eur J Pharmacol. 1994 Mar 21;254(3):299–302. doi: 10.1016/0014-2999(94)90470-7. [DOI] [PubMed] [Google Scholar]
  7. Giusti P., Ducić I., Puia G., Arban R., Walser A., Guidotti A., Costa E. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors. J Pharmacol Exp Ther. 1993 Aug;266(2):1018–1028. [PubMed] [Google Scholar]
  8. Grimm V. E., Hershkowitz M. The effect of chronic diazepam treatment on discrimination performance and 3H-flunitrazepam binding in the brains of shocked and nonshocked rats. Psychopharmacology (Berl) 1981;74(2):132–136. doi: 10.1007/BF00432679. [DOI] [PubMed] [Google Scholar]
  9. Haefely W., Martin J. R., Schoch P. Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci. 1990 Nov;11(11):452–456. doi: 10.1016/0165-6147(90)90126-s. [DOI] [PubMed] [Google Scholar]
  10. Haigh J. R., Feely M. RO 16-6028, a benzodiazepine receptor partial agonist, does not exhibit anticonvulsant tolerance in mice. Eur J Pharmacol. 1988 Mar 1;147(2):283–285. doi: 10.1016/0014-2999(88)90788-1. [DOI] [PubMed] [Google Scholar]
  11. Haigh J. R., Feely M. Tolerance to the anticonvulsant effect of benzodiazepines. Trends Pharmacol Sci. 1988 Oct;9(10):361–366. doi: 10.1016/0165-6147(88)90255-6. [DOI] [PubMed] [Google Scholar]
  12. Hernandez T. D., Heninger C., Wilson M. A., Gallager D. W. Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure. Eur J Pharmacol. 1989 Nov 7;170(3):145–155. doi: 10.1016/0014-2999(89)90535-9. [DOI] [PubMed] [Google Scholar]
  13. Landriani G. S., Guardabasso V., Rocchetti M. NL-FIT: a microcomputer program for non-linear fitting. Comput Programs Biomed. 1983 Feb-Apr;16(1-2):35–42. doi: 10.1016/0010-468x(83)90006-5. [DOI] [PubMed] [Google Scholar]
  14. Lewin E., Peris J., Bleck V., Zahniser N. R., Harris R. A. Diazepam sensitizes mice to FG 7142 and reduces muscimol-stimulated 36Cl- flux. Pharmacol Biochem Behav. 1989 Jun;33(2):465–468. doi: 10.1016/0091-3057(89)90531-5. [DOI] [PubMed] [Google Scholar]
  15. Lipartiti M., Arban R., Fadda E., Zanotti A., Giusti P. Characterization of [3H]-imidazenil binding to rat brain membranes. Br J Pharmacol. 1995 Mar;114(6):1159–1164. doi: 10.1111/j.1476-5381.1995.tb13328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marley R. J., Gallager D. W. Chronic diazepam treatment produces regionally specific changes in GABA-stimulated chloride influx. Eur J Pharmacol. 1989 Jan 17;159(3):217–223. doi: 10.1016/0014-2999(89)90151-9. [DOI] [PubMed] [Google Scholar]
  17. Miller L. G., Galpern W. R., Greenblatt D. J., Lumpkin M., Shader R. I. Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations. J Pharmacol Exp Ther. 1990 Jul;254(1):33–38. [PubMed] [Google Scholar]
  18. Miller L. G., Greenblatt D. J., Barnhill J. G., Shader R. I. Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function. J Pharmacol Exp Ther. 1988 Jul;246(1):170–176. [PubMed] [Google Scholar]
  19. Rosenberg H. C., Chiu T. H. Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding. Eur J Pharmacol. 1981 Apr 9;70(4):453–460. doi: 10.1016/0014-2999(81)90356-3. [DOI] [PubMed] [Google Scholar]
  20. Serra M., Ghiani C. A., Motzo C., Cuccheddu T., Floris S., Giusti P., Biggio G. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function. J Pharmacol Exp Ther. 1994 Apr;269(1):32–38. [PubMed] [Google Scholar]
  21. Serra M., Ghiani C. A., Motzo C., Porceddu M. L., Biggio G. Long-term treatment with abecarnil fails to induce tolerance in mice. Eur J Pharmacol. 1994 Jun 23;259(1):1–6. doi: 10.1016/0014-2999(94)90149-x. [DOI] [PubMed] [Google Scholar]
  22. Tallman J. F., Gallager D. W. The GABA-ergic system: a locus of benzodiazepine action. Annu Rev Neurosci. 1985;8:21–44. doi: 10.1146/annurev.ne.08.030185.000321. [DOI] [PubMed] [Google Scholar]
  23. Tietz E. I., Rosenberg H. C., Chiu T. H. Autoradiographic localization of benzodiazepine receptor downregulation. J Pharmacol Exp Ther. 1986 Jan;236(1):284–292. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES